Small molecules that bind the Mdm2 RING stabilize and activate p53. (Q53188125)

12 May 2018

title

Small molecules that bind the Mdm2 RING stabilize and activate p53. (English)

1 reference

12 May 2018

author

Peter M. Fischer

5

1 reference

12 May 2018

Karen Vousden

6

object named as

Karen H Vousden

1 reference

12 May 2018

author name string

Patricia Roxburgh

1

1 reference

12 May 2018

Andreas K Hock

2

1 reference

12 May 2018

Michael P Dickens

3

1 reference

12 May 2018

Mokdad Mezna

4

1 reference

12 May 2018

language of work or name

English

0 references

publication date

2 February 2012

1 reference

12 May 2018

published in

Carcinogenesis

1 reference

12 May 2018

volume

33

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

791-798

1 reference

12 May 2018

Mapping of the p53 and mdm-2 interaction domains

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Enhanced phosphorylation of p53 by ATM in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Regulation of HDM2 activity by the ribosomal protein L11

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Modeling the therapeutic efficacy of p53 restoration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Restoration of p53 function leads to tumour regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Structure-based design of potent non-peptide MDM2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Synthesis of 5-deazaflavin derivatives and their activation of p53 in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Regulating the p53 system through ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

A field guide to ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

A high-throughput screen measuring ubiquitination of p53 by human mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

An essential function of the extreme C-terminus of MDM2 can be provided by MDMX

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS092

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS092

1 reference

12 May 2018

PubMed ID

22301280

1 reference

12 May 2018